Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Tempest Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −2 vs. Q3 2021
- Shares held
- 2.35M
- +159.5K (+7.3%) vs. Q3 2021
- Total value
- $12.4M
- −$19.3M (−60.9%) vs. Q3 2021
- New holders
- 2
- 5 more added
- Sold out
- 4
- 5 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TPST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.44M |
| Q1 2026 | 22 | $1.29M |
| Q4 2025 | 21 | $2.26M |
| Q3 2025 | 17 | $6.02M |
| Q2 2025 | 18 | $6.42M |
| Q1 2025 | 24 | $4.42M |
| Q4 2024 | 35 | $5.66M |
| Q3 2024 | 28 | $3.94M |
| Q2 2024 | 24 | $4.70M |
| Q1 2024 | 30 | $7.58M |
| Q4 2023 | 32 | $9.88M |
| Q3 2023 | 24 | $1.05M |
| Q2 2023 | 22 | $4.86M |
| Q1 2023 | 17 | $8.72M |
| Q4 2022 | 13 | $3.54M |
| Q3 2022 | 16 | $5.36M |
| Q2 2022 | 16 | $6.67M |
| Q1 2022 | 15 | $7.12M |
| Q4 2021 | 19 | $12.4M |
| Q3 2021 | 22 | $31.8M |
| Q2 2021 | 24 | $20.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Tempest Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 823,654 | $4.35M | 0.10% | +513,493+165.6% | Added |
| FMR LLC | 647,898 | $3.42M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 291,308 | $1.54M | 0.00% | −67,858−18.9% | Reduced |
| FIL Ltd | 129,579 | $684.0K | 0.00% | 00.0% | Unchanged |
| NEA Management Company, LLC | 117,785 | $622.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 83,073 | $438.0K | 0.00% | +375+0.5% | Added |
| Maven Securities LTD | 77,377 | $409.0K | 0.05% | −49,506−39.0% | Reduced |
| Ikarian Capital, LLC | 58,803 | $310.0K | 0.09% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 50,430 | $266.0K | 0.00% | +16,326+47.9% | Added |
| Geode Capital Management, LLC | 34,346 | $181.0K | 0.00% | +11,045+47.4% | Added |
| Franklin Resources Inc | 15,240 | $80.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 14,628 | $77.0K | 0.00% | −14,444−49.7% | Reduced |
| Tower Research Capital LLC (TRC) | 2,744 | $15.0K | 0.00% | +2,744 | New |
| Morgan Stanley | 1,803 | $10.0K | 0.00% | −186−9.4% | Reduced |
| Bank of America Corp | 912 | $5.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 192 | $1.00K | 0.00% | −1,310−87.2% | Reduced |
| Wells Fargo & Company | 35 | $0 | 0.00% | +2+6.1% | Added |
| Baystate Wealth Management LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 4 | $0 | 0.00% | +4 | New |
| Foresite Capital Management IV, LLC | 0 | $0 | 0.00% | −190,213−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −983−100.0% | Sold out |
| Atlas Private Wealth Advisors | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Knott David M | – | – | – | – | Not filed |